Manufacturer record

Escape Lifesciences Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Escape Lifesciences Pvt. Ltd (Uttarakhand) was declared Not of Standard Quality in June 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: R-132, Cefixime Tablets IP (MICRA-200 Tablets) (exp Jan 2020). RDTL Chandigarh (state lab) found it not of standard quality: Identification & Assay. Listed in the June 2019 alert.

Records by type

1 record linked to Escape Lifesciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2019 to Jun 2019

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2019
1
Products affected
Assay
Most common failure
Jun 2019
Latest alert

Flagged batches per year

2019 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefixime Tablets IP (MICRA-200 Tablets) Batch R-132Mfg Feb 2018 · Exp Jan 2020 Identification & AssayAssay RDTL ChandigarhState lab Jun 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.